Edition:
United Kingdom

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

9.89USD
25 Apr 2019
Change (% chg)

$0.31 (+3.24%)
Prev Close
$9.58
Open
$9.58
Day's High
$9.96
Day's Low
$9.42
Volume
36,937
Avg. Vol
70,370
52-wk High
$20.97
52-wk Low
$9.23

Tung, Roger 

Dr. Roger Tung is the Co-Founder, President, Director and CEO of Concert Pharmaceuticals Inc. Before thisBefore Concert, Dr. Tung was a founding scientist at Vertex, a pharmaceutical company, where he was employed from 1989 to 2005, most recently as its Vice President of Drug Discovery. Prior to Vertex, he held various positions at Merck, Sharp & Dohme Research Laboratories, a global healthcare provider, and The Squibb Institute for Medicinal Chemistry. Dr. Tung received a B.A. in Chemistry from Reed College and a Ph.D. in Medicinal Chemistry at the University of Wisconsin-Madison. We believe that Dr. Tung’s detailed knowledge of our company and his 28 year career in the global pharmaceutical and biotechnology industries, including his roles at Vertex, provide a critical contribution to our board of directors.

Basic Compensation

Total Annual Compensation, USD 517,402
Restricted Stock Award, USD 1,109,600
Long-Term Incentive Plans, USD --
All Other, USD 1,803,850
Fiscal Year Total, USD 3,430,850

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

167,720

Roger Tung

3,430,850

Marc Becker

--

Nancy Stuart

1,947,300

Lynette Herscha

--

James Cassella,

1,960,240
As Of  31 Dec 2017